王维. 利可君片联合更昔洛韦治疗巨细胞病毒性肝炎婴儿的效果分析[J]. 实用临床医药杂志, 2019, (1): 115-117. DOI: 10.7619/jcmp.201901032
引用本文: 王维. 利可君片联合更昔洛韦治疗巨细胞病毒性肝炎婴儿的效果分析[J]. 实用临床医药杂志, 2019, (1): 115-117. DOI: 10.7619/jcmp.201901032
WANG Wei. Efficiency analysis of leucogen tablets combined with ganciclovir in the treatment of infants with cytomegalovirus hepatitis[J]. Journal of Clinical Medicine in Practice, 2019, (1): 115-117. DOI: 10.7619/jcmp.201901032
Citation: WANG Wei. Efficiency analysis of leucogen tablets combined with ganciclovir in the treatment of infants with cytomegalovirus hepatitis[J]. Journal of Clinical Medicine in Practice, 2019, (1): 115-117. DOI: 10.7619/jcmp.201901032

利可君片联合更昔洛韦治疗巨细胞病毒性肝炎婴儿的效果分析

Efficiency analysis of leucogen tablets combined with ganciclovir in the treatment of infants with cytomegalovirus hepatitis

  • 摘要: 目的 探讨利可君片联合更昔洛韦治疗巨细胞病毒性(CMV)肝炎婴儿的临床效果.方法 选取60例CMV肝炎患儿,随机分为对照组和观察组各30例.对照组采用更昔洛韦治疗,观察组在此基础上联合利可君片治疗.比较2组肝功能、巨细胞病毒载量(HCMV-DNA)以及治疗转归情况.结果 观察组治疗后谷丙转氨酶及总胆红素均显著低于对照组(P<0.05);观察组治疗后HCMV-DNA载量水平显著低于对照组(P<0.05);观察组临床症状转归情况显著优于对照组(P<0.05);观察组不良反应发生率6.67%,显著低于对照组43.33% (P <0.05).结论 利可君片联合更昔洛韦治疗CMV肝炎婴儿的疗效肯定,安全性高.

     

/

返回文章
返回